NASDAQ:PDEX Pro-Dex (PDEX) Stock Forecast, Price & News $15.81 +0.01 (+0.06%) (As of 09/21/2023 08:57 PM ET) Add Compare Share Share Today's Range$15.80▼$16.0050-Day Range$15.66▼$18.8852-Week Range$14.47▼$21.00Volume1,900 shsAverage Volume4,036 shsMarket Capitalization$56.13 millionP/E Ratio12.45Dividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Pro-Dex (NASDAQ:PDEX) StockPro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.Read More PDEX Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PDEX Stock News HeadlinesSeptember 21, 2023 | americanbankingnews.comPro-Dex (NASDAQ:PDEX) Now Covered by StockNews.comSeptember 21, 2023 | americanbankingnews.comPro-Dex (NASDAQ:PDEX) Share Price Crosses Below Two Hundred Day Moving Average of $17.35September 25, 2023 | Chaikin Analytics (Ad)This is the #1 Stock to Buy for the AI Tidal WaveMarc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.September 17, 2023 | americanbankingnews.comComparing Carl Zeiss Meditec (OTCMKTS:CZMWY) and Pro-Dex (NASDAQ:PDEX)August 7, 2023 | finance.yahoo.comPro-Dex's (NASDAQ:PDEX) Returns Have Hit A WallJune 29, 2023 | finance.yahoo.comAt US$18.26, Is It Time To Put Pro-Dex, Inc. (NASDAQ:PDEX) On Your Watch List?June 5, 2023 | finanznachrichten.deStock Day Media: Pro-Dex, Inc. Discusses Record 3rd Quarter Results with The Stock Day PodcastJune 5, 2023 | finance.yahoo.comPro-Dex, Inc. Discusses Record 3rd Quarter Results with The Stock Day PodcastSeptember 25, 2023 | Chaikin Analytics (Ad)This is the #1 Stock to Buy for the AI Tidal WaveMarc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.May 30, 2023 | finance.yahoo.comPro-Dex (NASDAQ:PDEX) shareholders have earned a 23% CAGR over the last five yearsMay 4, 2023 | finance.yahoo.comPro-Dex, Inc. Announces Fiscal 2023 Third Quarter and Nine-Month ResultsApril 20, 2023 | seekingalpha.comPDEX Pro-Dex, Inc.March 31, 2023 | finance.yahoo.comOne Pro-Dex, Inc. (NASDAQ:PDEX) insider upped their stake by 36% in the previous yearFebruary 27, 2023 | finance.yahoo.comPro-Dex's (NASDAQ:PDEX) Returns On Capital Not Reflecting Well On The BusinessFebruary 14, 2023 | finance.yahoo.comPro-Dex, Inc. Discusses 2nd Quarter Results and 2023 Growth Strategy with The Stock Day PodcastFebruary 2, 2023 | msn.comPro-Dex GAAP EPS of $0.24 misses by $0.05, revenue of $11.28M beats by $0.88MFebruary 2, 2023 | finance.yahoo.comPro-Dex, Inc. Announces Fiscal 2023 Second Quarter and Six-Month ResultsJanuary 30, 2023 | seekingalpha.comPro-Dex Is Growing But Expensive Given Its RiskJanuary 20, 2023 | finance.yahoo.comWhy Pro-Dex, Inc. (NASDAQ:PDEX) Could Be Worth WatchingJanuary 18, 2023 | reuters.comPDEX.A - | Stock Price & Latest News | ReutersDecember 21, 2022 | finance.yahoo.comPro-Dex (NASDAQ:PDEX) shareholders have earned a 19% CAGR over the last five yearsNovember 25, 2022 | msn.comPro-Dex Earnings Perspective: Return On Invested CapitalNovember 23, 2022 | finance.yahoo.comDeclining Stock and Solid Fundamentals: Is The Market Wrong About Pro-Dex, Inc. (NASDAQ:PDEX)?November 9, 2022 | finance.yahoo.comPro-Dex First Quarter 2023 Earnings: Revenues Beat Expectations, EPS LagsNovember 4, 2022 | finance.yahoo.comPro-Dex, Inc. Announces Fiscal 2023 First Quarter ResultsOctober 22, 2022 | finance.yahoo.comQuite a few insiders invested in Pro-Dex, Inc. (NASDAQ:PDEX) last year which is positive news for shareholdersOctober 17, 2022 | nasdaq.comPro-Dex (NASDAQ:PDEX) May Have Issues Allocating Its CapitalSee More Headlines Receive PDEX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter. Email Address PDEX Company Calendar Last Earnings11/15/2021Today9/25/2023Next Earnings (Estimated)9/28/2023Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:PDEX CUSIPN/A CIK788920 Webwww.pro-dex.com Phone(949) 769-3200Fax949-769-3281Employees134Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$1.27 Trailing P/E Ratio12.45 Forward P/E RatioN/A P/E GrowthN/ANet Income$3.86 million Net Margins9.72% Pretax Margin11.92% Return on Equity19.00% Return on Assets9.85% Debt Debt-to-Equity Ratio0.36 Current Ratio3.07 Quick Ratio1.58 Sales & Book Value Annual Sales$42.04 million Price / Sales1.34 Cash Flow$1.29 per share Price / Cash Flow12.24 Book Value$6.54 per share Price / Book2.42Miscellaneous Outstanding Shares3,550,000Free Float2,035,000Market Cap$56.13 million OptionableNot Optionable Beta0.92 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Richard Lee Van Kirk Jr. (Age 62)CEO & Director Comp: $416.38kMs. Alisha K. Charlton (Age 53)CFO & Corp. Sec. Comp: $300.22kKey CompetitorsMeihua International Medical TechnologiesNASDAQ:MHUAAkiliNASDAQ:AKLIenVVeno MedicalNASDAQ:NVNOLucid DiagnosticsNASDAQ:LUCDDelcath SystemsNASDAQ:DCTHView All CompetitorsInstitutional OwnershipNorthern Trust CorpBought 776 shares on 8/11/2023Ownership: 0.556%View All Institutional Transactions PDEX Stock - Frequently Asked Questions How have PDEX shares performed in 2023? Pro-Dex's stock was trading at $15.90 at the beginning of 2023. Since then, PDEX shares have decreased by 0.6% and is now trading at $15.81. View the best growth stocks for 2023 here. When is Pro-Dex's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, September 28th 2023. View our PDEX earnings forecast. How were Pro-Dex's earnings last quarter? Pro-Dex, Inc. (NASDAQ:PDEX) announced its earnings results on Monday, November, 15th. The medical instruments supplier reported $0.28 earnings per share for the quarter, meeting analysts' consensus estimates of $0.28. The medical instruments supplier had revenue of $9.99 million for the quarter. Pro-Dex had a trailing twelve-month return on equity of 19.00% and a net margin of 9.72%. What is Michael J. Berthelot's approval rating as Pro-Dex's CEO? 3 employees have rated Pro-Dex Chief Executive Officer Michael J. Berthelot on Glassdoor.com. Michael J. Berthelot has an approval rating of 85% among the company's employees. What other stocks do shareholders of Pro-Dex own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pro-Dex investors own include KEMET (KEM), NVIDIA (NVDA), Enterprise Products Partners (EPD), Micron Technology (MU), AT&T (T), AbbVie (ABBV), Alibaba Group (BABA), Bank of America (BAC), Marvell Technology (MRVL) and UnitedHealth Group (UNH). What is Pro-Dex's stock symbol? Pro-Dex trades on the NASDAQ under the ticker symbol "PDEX." Who are Pro-Dex's major shareholders? Pro-Dex's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Northern Trust Corp (0.56%). Insiders that own company stock include Alisha Charlton, Katrina Marie Kramer Philp, Nicholas John Swenson, Raymond E Cabillot and William James Farrell III. View institutional ownership trends. How do I buy shares of Pro-Dex? Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Pro-Dex's stock price today? One share of PDEX stock can currently be purchased for approximately $15.81. How much money does Pro-Dex make? Pro-Dex (NASDAQ:PDEX) has a market capitalization of $56.13 million and generates $42.04 million in revenue each year. The medical instruments supplier earns $3.86 million in net income (profit) each year or $1.27 on an earnings per share basis. How many employees does Pro-Dex have? The company employs 134 workers across the globe. How can I contact Pro-Dex? Pro-Dex's mailing address is 2361 MCGAW AVENUE, IRVINE CA, 92614. The official website for the company is www.pro-dex.com. The medical instruments supplier can be reached via phone at (949) 769-3200, via email at investor.relations@pro-dex.com, or via fax at 949-769-3281. This page (NASDAQ:PDEX) was last updated on 9/25/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.